Article
Ex vivo gene transfer for improved adoptive immunotherapy of cancer
17 Mar 2011
Abstract excerpt
Adoptive immunotherapy is an appealing approach to cancer treatment, with the potential for more precise targeting and reduced toxicity. While early clinical trial data using adoptive T cells against post-transplant virus-associated hematologic malignancies, lymphoma and melanoma have been promising, treating other solid tumors has proven to be more challenging. Adoptive lymphocytes have been genetically modified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
